Fairmount Funds Management LLC

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value
Latest Disclosed Shares Owned: 16,025,330 shares
Security Ownership %: 15%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN)

27 Oct 2025 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16,025,330 shares of Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN). This represents 15% ownership of the company. This is the first filing by Fairmount Funds Management LLC disclosing ownership of Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Fairmount Funds Management LLC	15%		$345,826,621	16,025,330			$21.58	13D/A	23 Oct 2025	27 Oct 2025, 16:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	9.3%	+1.1%	$121,817,933	3,914,458	+454,545	+13%	$31.12	Q4 2025
30 Sep 2025	6.7%	0%	$74,664,923	3,459,913	0		$21.58	Q3 2025
30 Jun 2025	6.3%	+0.03%	$48,369,584	3,459,913	+14,100	+0.41%	$13.98	Q2 2025
31 Mar 2025	7.2%	0%	$46,449,559	3,445,813	0		$13.48	Q1 2025
31 Dec 2024	6.6%	0%	$66,056,235	3,445,813	0		$19.17	Q4 2024
30 Sep 2024	6.4%	+3%	$78,392,246	3,445,813	+1,600,000	+87%	$22.75	Q3 2024
30 Jun 2024	2.7%	0%	$24,014,027	1,845,813	0		$13.01	Q2 2024
31 Mar 2024	3.5%	+0.91%	$32,320,186	1,845,813	+476,190	+35%	$17.51	Q1 2024
31 Dec 2023	3.2%	0%	$29,830,389	1,369,623	0		$21.78	Q4 2023
30 Sep 2023	2.5%	0%	$21,010,017	1,369,623	0		$15.34	Q3 2023
30 Jun 2023	4.6%	0%	$32,583,331	1,369,623	0		$23.79	Q2 2023
31 Mar 2023	6%	0%	$34,843,209	1,369,623	0		$25.44	Q1 2023
31 Dec 2022	6.3%	0%	$40,006,688	1,369,623	0		$29.21	Q4 2022
30 Sep 2022	5.2%	+1.6%	$28,091,000	1,369,623	+425,531	+45%	$20.51	Q3 2022
30 Jun 2022	2.5%	0%	$10,923,000	944,092	0		$11.57	Q2 2022
31 Mar 2022	4.1%	0%	$17,456,000	944,092	0		$18.49	Q1 2022
31 Dec 2021	6.2%	0%	$18,665,000	944,092	0		$19.77	Q4 2021
30 Sep 2021	5.6%	+5.4%	$15,530,000	944,092	+909,000	+2590%	$16.45	Q3 2021
30 Jun 2021	0.26%	0%	$642,000	35,092	0		$18.29	Q2 2021
31 Mar 2021	0.24%	+0.24%	$581,000	35,092	+35,092	NEW	$16.56	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.